Christine Mundkur serves as Executive at BARR PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Christine Mundkur has executed 11 insider transactions totaling $75.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 5, 2025 involved receiving (via award) 1,067 shares valued at $0.
Christine Mundkur currently holds 7,536 shares of BARR PHARMACEUTICALS INC (BRL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christine Mundkur has been a net buyer of BRL stock. They have purchased $75.0K and sold $0 worth of shares.
Christine Mundkur's most recent insider trade was on Nov 5, 2025, when they sold 1,067 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 9, 2022 | CAH | $0 | Award | 2,308 | $N/A | Discretionary |
| Sep 15, 2022 | CAH | $0 | Award | 466 | $N/A | Discretionary |
| Feb 28, 2022 | MNKD | $75.0K | Purchase | 27,675 | $2.71 | Discretionary |
| Feb 20, 2019 | MNKD | $0 | Award | 32,608 | $N/A | Discretionary |
| Dec 23, 2008 | BRL | $0 | Disposition | 5,406 | $N/A | Discretionary |
| Nov 18, 2008 | BRL | $100.1K | Option Exercise | 2,310 | $43.34 | Discretionary |
| Nov 18, 2008 | BRL | $100.0K | Option Exercise | 2,128 | $46.99 | Discretionary |
| May 13, 2008 | BRL | $100.0K | Option Exercise | 2,856 | $35.01 | Discretionary |
| May 13, 2008 | BRL | $299.8K | Option Exercise | 11,278 | $26.58 | Discretionary |